Attached files
| file | filename |
|---|---|
| 10-Q - 10-Q - GENOCEA BIOSCIENCES, INC. | gnca-20150930x10q.htm |
| EX-32.2 - EXHIBIT 32.2 - GENOCEA BIOSCIENCES, INC. | gnca-ex322_20150930xq3.htm |
| EX-31.2 - EXHIBIT 31.2 - GENOCEA BIOSCIENCES, INC. | gnca-ex312_20150930xq3.htm |
| EX-31.1 - EXHIBIT 31.1 - GENOCEA BIOSCIENCES, INC. | gnca-ex311_20150930xq3.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Genocea Biosciences, Inc. (the “Company”) for the period ended September 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, the undersigned, William D. Clark, as the President & Chief Executive Officer of the Company, does hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
/s/ WILLIAM D. CLARK | |
William D. Clark* | |
President &Chief Executive Officer | |
Date: November 5, 2015 | |
* A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of Section 1350, Chapter 63 of Title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.